BIRC2 and breast carcinoma: We also identified BIRC2, an apoptosis inhibitor and therapeutic target in various cancers [51]; MAGI1-AS1, an antisense RNA to the tumor suppressor MAGI1 that may promote tumorigenesis by suppressing MAGI1 function [52]; C6orf99, a suggested breast cancer biomarker [53]; ABHD17C, which participates in protein palmitoylation affecting membrane-associated oncogenic signaling [54]; and HAS3, which synthesizes hyaluronan to shape the tumor microenvironment and enhance cancer cell migration [55].